Oct 15 (Reuters) - Bayer (BAYGn.DE), opens new tab on Tuesday said it had applied for marketing authorization with the European Medicines Agency (EMA) for its menopause relief drug elinzanetant.

Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing treatments for neurodegenerative diseases, is pleased to announce it has ...

The European Medicines Agency (EMA) has rejected a licence for an Alzheimer’s treatment which slows cognitive decline. The EMA said the benefits of lecanemab did not counterbalance the risk of ...

Rolling Submission of NDA for Aficamten Completed and Submitted to FDA in Q3COMET-HF, Confirmatory Phase 3 Clinical Trial of Omecamtiv ...

BERLIN, Oct 14 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Monday that it has applied to the EU's drugs regulator for the use of Nubeqa, also known as darolutamide, in combination with ...

Directive Might Cause Massive Medicine Shortages Affecting Millions Of Patients Across Europe ...

122, Issue. 2, p. 191. Modern languages like English, Spanish, Russian and Hindi as well as ancient languages like Greek, Latin and Sanskrit all belong to the Indo-European language family, which ...

The global periodontal disease treatment market is projected to reach USD 3.63 billion by 2030 from USD 2.58 billion in 2024, ...

European Criminal Law has developed into a complex, jagged subject matter, which at the same time has become increasingly important for everyday criminal law practice. On the one hand, this work aims ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...